Trial
NCT03760250
Imiquimod for Preventing Keloid Recurrence
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
—
Condition
Keloid
Intervention
Imiquimod 5% cream
Why stopped
Investigator decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-11-19